Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis

scientific article published on 01 May 1999

Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0165-5728(99)00040-5
P698PubMed publication ID10337924

P50authorNobuhiro YukiQ66672559
P2093author name stringK Hirata
M Koga
P2860cites workAssessment of current diagnostic criteria for Guillain-Barré syndromeQ22252936
Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infectionQ28284306
Molecular heterogeneity of human IgA antibodies during an immune response.Q36750610
Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response.Q39657235
Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor functionQ42123972
Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1 alphaQ42549991
Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritisQ42551712
GM1b is a new member of antigen for serum antibody in Guillain-Barré syndromeQ42634595
Modulating the immune response in demyelinating diseasesQ42911892
N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndromeQ43439827
Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndromeQ45191246
Anti-GM1 IgA antibodies in Guillain-Barré syndromeQ67744269
Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritisQ68614125
Anti-GD1a ganglioside antibodies in peripheral motor syndromesQ71053650
Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndromeQ71444464
Potential role of transforming growth factor-beta 1 in terminating the immune response in patients with Guillain-Barré syndromeQ71817926
Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromesQ74377577
P433issue2
P921main subjectGuillain–Barré syndromeQ205214
Campylobacter jejuniQ265488
P304page(s)245-250
P577publication date1999-05-01
P1433published inJournal of NeuroimmunologyQ15716691
P1476titleSubclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis
P478volume96